These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31603597)

  • 1. Prognostic factors influencing the treatment outcome of onychomycosis Candida.
    Widaty S; Miranda E; Bramono K; Menaldi SL; Marissa M; Oktarina C; Surya D; Kusumawardhani HT
    Mycoses; 2020 Jan; 63(1):71-77. PubMed ID: 31603597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of Candida isolation from dystrophic fingernails.
    Shemer A; Daniel R; Lyakhovitsky A; Aghion-Svirsky V; Kassem R; Rigopoulos D; Farhi R; Galili E
    Mycoses; 2020 Sep; 63(9):964-969. PubMed ID: 32563206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
    Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
    Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents.
    Sigurgeirsson B; Paul C; Curran D; Evans EG
    Br J Dermatol; 2002 Dec; 147(6):1241-3. PubMed ID: 12452877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onychomycosis secondary to onychomadesis: an underdiagnosed manifestation.
    Li M; Chen Z; Yin S; Xue R; Chen Z; Huang H; Wei L; Lu C; De Hoog GS; Lai W; Feng P
    Mycoses; 2017 Mar; 60(3):161-165. PubMed ID: 27618806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous terbinafine and pulse itraconazole for the treatment of non-dermatophyte mold toenail onychomycosis.
    Shemer A; Gupta AK; Kamshov S; Babaev M; Hermush V; Farhi R; Daniel CR; Foley KA
    J Dermatolog Treat; 2021 May; 32(3):310-313. PubMed ID: 31415182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for mycological cure in patients with onychomycosis caused by Neoscytalidium dimidiatum: A retrospective cohort study.
    Leeyaphan C; Chai-Adisaksopha C; Tovanabutra N; Phinyo P; Bunyaratavej S
    Mycoses; 2023 Jun; 66(6):497-504. PubMed ID: 36740753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall Prevalence and Prevalence Compared among Psoriasis Treatments of Onychomycosis in Patients with Nail Psoriasis and Fungal Involvement.
    Chularojanamontri L; Pattanaprichakul P; Leeyaphan C; Suphatsathienkul P; Wongdama S; Bunyaratavej S
    Biomed Res Int; 2021; 2021():9113418. PubMed ID: 34938812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
    Shemer A; Nathansohn N; Kaplan B; Trau H
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):279-82. PubMed ID: 18269594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pharmacokinetic studies of continuous itraconazole for the treatment of onychomycosis.
    Kawada A; Aragane Y; Tezuka T
    J Dermatol; 2004 Feb; 31(2):104-8. PubMed ID: 15160863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological periodic acid-schiff stains of nail clippings as a second-line diagnostic tool in onychomycosis.
    Mayer E; Izhak OB; Bergman R
    Am J Dermatopathol; 2012 May; 34(3):270-3. PubMed ID: 22452952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for cure following treatment of onychomycosis.
    Sigurgeirsson B
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):679-84. PubMed ID: 19929941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals.
    Tosti A; Piraccini BM; Stinchi C; Lorenzi S
    Br J Dermatol; 1996 Nov; 135(5):799-802. PubMed ID: 8977686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
    Elewski BE; Ghannoum MA; Mayser P; Gupta AK; Korting HC; Shouey RJ; Baker DR; Rich PA; Ling M; Hugot S; Damaj B; Nyirady J; Thangavelu K; Notter M; Parneix-Spake A; Sigurgeirsson B
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):287-94. PubMed ID: 22181693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onychomycosis in psoriatic patients - rationalization of systemic treatment.
    Shemer A; Trau H; Davidovici B; Grunwald MH; Amichai B
    Mycoses; 2010 Jul; 53(4):340-3. PubMed ID: 19496936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One week pulse therapy with itraconazole (200 mg day-1) for onychomycosis. Evaluation of treatment results according to patient background.
    Hiruma M; Matsushita A; Kobayashi M; Ogawa H
    Mycoses; 2001 May; 44(3-4):87-93. PubMed ID: 11413929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimycotic therapy of Tinea unguium and other onychomycoses].
    Stock I
    Med Monatsschr Pharm; 2009 Aug; 32(8):289-98; quiz 299-300. PubMed ID: 19777736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment.
    Grynszpan R; Barreiros G; do Nascimento Paixão M; Frasnelli Fernandes M; Aguinaga F; Camargo C; Ramos-E-Silva M; Carneiro S
    Mycoses; 2021 Sep; 64(9):1092-1097. PubMed ID: 34061419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of Candida onychomycosis in Southeastern Serbia from 2011 to 2015.
    Otašević S; Barac A; Pekmezovic M; Tasic S; Ignjatović A; Momčilović S; Stojanović P; Arsic Arsenijevic V; Hay R
    Mycoses; 2016 Mar; 59(3):167-72. PubMed ID: 26710983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.